Award
National Institute of Allergy and Infectious Diseases 5R01AI184895-03
Multivalent mRNA-based malaria vaccines
Recipient
DREXEL UNIVERSITY
Award Amount
$718,445.00
Ceiling
$718,445.00
Awarded
July 24, 2026
Identifier
5R01AI184895-03
Award for developing a multistage malaria vaccine using mRNA technology, targeting multiple malaria antigens, with a project duration of five years.
Description
The project focuses on evaluating mRNA technology for malaria vaccine delivery. The project involves multiple targets including PfCSP, PfRh5, and PfMSP119. The project aims to develop a multistage malaria vaccine using mRNA technology. The project duration is from August 1, 2024, to July 31, 2029.